Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06035523 · ClinicalTrials.gov registry record · NA
Clinical Study Evaluating Wound Closure With Endoform™ and Symphony™
A NA study of Diabetic Foot and Foot Ulcer, sponsored by Aroa Biosurgery Limited.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 4
- Study locations
NCT06035523: Completed NA study of Diabetic Foot and Foot Ulcer, sponsored by Aroa Biosurgery Limited.
NCT06035523 is a NA study of Diabetic Foot and Foot Ulcer that has completed, run by Aroa Biosurgery Limited. The registered enrollment target is 44 participants, below the 10,340-participant average among 30 other Diabetic Foot trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06035523, a NA study of Diabetic Foot and Foot Ulcer, has completed, sponsored by Aroa Biosurgery Limited.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 4
- Study locations
Study Summary
Study will evaluate the performance and safety of Endoform™ Natural and Endoform™ Antimicrobial in conjunction with Symphony™ in the treatment of chronic non-healing diabetic foot ulcers after 12 weeks of treatment.
Primary Outcome
Percentage of index ulcer defined as 100% re-epithelialization within 12 weeks
Conditions Studied
Interventions
- DEVICE Endoform™ Antibacterial
- DEVICE Endoform™ Natural
- DEVICE Symphony™
Study Locations (4)
Florida
- South Florida Lower Extremity Center - Hollywood
- Advanced Pharma Cr, LLC - Miami
Virginia
- Foot and Ankle Specialists of the Mid-Atlantic - Salem
Washington
- Madigan Army Medical Center - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2021-12-29 |
| Est. Completion | 2025-08-30 |
| Phase | NA |
What the finished NCT06035523 record still lists
NCT06035523 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 10,340-participant average among 30 other Diabetic Foot trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Diabetic Foot appearing as the primary indexed condition, and to 3 interventions - of which Endoform™ Antibacterial is the first listed.
NCT06035523 reports a single indexed study location in Florida, Virginia, Washington.
Frequently Asked Questions
What is clinical trial NCT06035523 about?
NCT06035523 is a clinical study titled "Clinical Study Evaluating Wound Closure With Endoform™ and Symphony™". Study will evaluate the performance and safety of Endoform™ Natural and Endoform™ Antimicrobial in conjunction with Symphony™ in the treatment of chronic non-healing diabetic foot ulcers after 12 weeks of treatment.
What is the current status of trial NCT06035523?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2021-12-29. Estimated completion is 2025-08-30.
What conditions does trial NCT06035523 study?
This clinical trial studies the following conditions: Diabetic Foot, Foot Ulcer, Wound Healing, Chronic Foot Ulcer.
What interventions are being tested in trial NCT06035523?
The interventions under investigation include: Endoform™ Antibacterial (DEVICE), Endoform™ Natural (DEVICE), Symphony™ (DEVICE).
Who is sponsoring clinical trial NCT06035523?
This trial is sponsored by Aroa Biosurgery Limited, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06035523 being conducted?
This trial has 4 study locations across Florida, Virginia, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06035523's enrollment target sits among peer trials
44 28th of 30 higher than 3 of 30 other Diabetic Foot trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Effectiveness of Remote Foot Temperature Monitoring
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care
RECRUITING · NA
-
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers
RECRUITING · NA
-
Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI